Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.67% | -38.39% | -44.87% | -52.19% | -60.35% |
| Total Depreciation and Amortization | -24.07% | -16.92% | -3.80% | 11.84% | 22.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.37% | 38.81% | 46.01% | 56.11% | 75.98% |
| Change in Net Operating Assets | -266.41% | -348.81% | -123.53% | 774.38% | 329.47% |
| Cash from Operations | -47.06% | -50.30% | -48.58% | -45.75% | -41.78% |
| Capital Expenditure | 82.03% | 79.67% | 44.41% | 30.69% | 14.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 312.02% | -96.12% | -199.06% | -325.82% | -193.08% |
| Cash from Investing | 297.87% | -96.87% | -206.30% | -342.24% | -206.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -120.13% | -588.75% | -597.99% | -- | -- |
| Issuance of Common Stock | 89.34% | 2,280.78% | 747.93% | 1.29% | 1.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 87.92% | 2,854.71% | 759.36% | -3.95% | -3.11% |
| Foreign Exchange rate Adjustments | -316.67% | 92.31% | 195.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 340.87% | 65.04% | -176.61% | -300.34% | -165.30% |